KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Quest Diagnostics (DGX) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to 0.45.

  • Quest Diagnostics' Equity Ratio rose 596.49% to 0.45 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.45, marking a year-over-year increase of 596.49%. This contributed to the annual value of 0.42 for FY2024, which is 674.57% down from last year.
  • As of Q3 2025, Quest Diagnostics' Equity Ratio stood at 0.45, which was up 596.49% from 0.45 recorded in Q2 2025.
  • In the past 5 years, Quest Diagnostics' Equity Ratio ranged from a high of 0.49 in Q1 2021 and a low of 0.42 during Q4 2024
  • In the last 5 years, Quest Diagnostics' Equity Ratio had a median value of 0.47 in 2023 and averaged 0.46.
  • In the last 5 years, Quest Diagnostics' Equity Ratio tumbled by 1133.57% in 2024 and then surged by 596.49% in 2025.
  • Quest Diagnostics' Equity Ratio (Quarter) stood at 0.48 in 2021, then decreased by 3.01% to 0.46 in 2022, then decreased by 2.09% to 0.45 in 2023, then decreased by 6.75% to 0.42 in 2024, then grew by 6.78% to 0.45 in 2025.
  • Its Equity Ratio stands at 0.45 for Q3 2025, versus 0.45 for Q2 2025 and 0.44 for Q1 2025.